How financial investors can effectively protect investments against healthcare compliance risks

The healthcare market continues to be an attractive area for financial investors, with a total value of healthcare buyouts at more than $16bn in 2013. At the same time, the globalhealthcare sector is facing a significant shake-up in relation to compliance and anti-bribery requirements, exposing both the portfolio company as well as financial investors and theirmanagement to very significant risks that can have a detrimental effect on the value and marketability of the investment – investigation costs, unlimited fines, possible debarment,confiscation of revenue and reputational damage.